홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Chlorosuccinimide → Tert-butyl 3-chloro-4-(4-methylpiperazin-1-yl)benzylcarbamate

HRID 1819679
인쇄

반응식

HRID 1819679 반응식
[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[CH:22]=[CH:21][C:11]([CH2:12][NH:13][C:14](=[O:20])[O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[CH:10][CH:9]=2)[CH2:4][CH2:3]1.C1C(=O)N([Cl:30])C(=O)C1>C(Cl)Cl>[Cl:30][C:22]1[CH:21]=[C:11]([CH:10]=[CH:9][C:8]=1[N:5]1[CH2:4][CH2:3][N:2]([CH3:1])[CH2:7][CH2:6]1)[CH2:12][NH:13][C:14](=[O:20])[O:15][C:16]([CH3:19])([CH3:17])[CH3:18]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 31398ChlorosuccinimideHCID 69062408tert-Butyl 4-(4-methylpiperazin-1-yl)benzylcarbamate

생성물 1

HCID 69058940Tert-butyl 3-chloro-4-(4-methylpiperazin-1-yl)benzylcarbamate

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

Step F (2): To a solution of tert-butyl 4-(4-methylpiperazin-1-yl)benzylcarbamate (30 mg, 0.1 mmol) from step F (1) in CH2Cl2 (1.0 mL) was added NCS (14 mg, 0.1 mmol). The mixture was stirred at rt for 4 h, and then the mixture was concentrated to give tert-butyl 3-chloro-4-(4-methylpiperazin-1-yl)benzylcarbamate which was used without purification in the next step. LC-MS (M+H)+=340.29 1H-NMR (500 MHz, CD3OD) δ 7.30 (s, 1 H), 7.18 (d, J=8.24 Hz, 1 H), 7.10 (d, J=8.24 Hz, 1 H), 4.16 (s, 2 H), 3.00-3.15 (m, 4 H), 2.62-2.81 (m, 7 H), 1.50(s, 9 H).

후처리

  1. concentrationthe mixture was concentrated

출처 및 근거

ORD 기록
ord-8d3248995636423dbedb4423722a3619
출처 데이터셋
uspto-grants-2009_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07601751B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트